Personalizing Plavix: Eric Topol Champions Genotyping For Stent Patients
This article was originally published in The Gray Sheet
Executive Summary
Genotyping patients to help optimize treatment with the widely prescribed anti-clotting drug clopidogrel can be a successful model for the nascent pharmacogenetic testing market, according to Scripps Health exec and cardiologist Eric Topol
You may also be interested in...
Companion Dx Partnerships, M&A Deals Help Spur IVD Market Growth – PWC Report
A report from PricewaterhouseCoopers suggests the in vitro diagnostics market will see accelerated growth next year due in part to a surge in companion diagnostics partnerships and M&A deals.
Companion Dx Partnerships, M&A Deals Help Spur IVD Market Growth – PWC Report
A report from PricewaterhouseCoopers suggests the in vitro diagnostics market will see accelerated growth next year due in part to a surge in companion diagnostics partnerships and M&A deals.
In Vitro Diagnostics: The Quest For Growth
This article first appeared in Medtech Insight, October 2010.